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ABSTRACT
Background: Premature rupture of membrane (PROM) is the rupture of fetal membranes at 
least 1 hour before the onset of labor pain. In this study, we sought to determine the predictive 
value of maternal serum level of procalcitonin (PCT) in the early diagnosis of chorioamnionitis 
in women with preterm PROM (PPROM). Methods: In this prospective cohort study, owing to 
limited financial resources, 48 patients with PPROM in the Kosar Ward of Motahari Hospital in 
Urmia, Iran were selected to comprise the sample. Inclusion criteria were amniotic fluid leak, 
positive ferning and nitrazine tests, gestational age 28-33 weeks, and lack of fetal tachycardia. 
Exclusion criteria were chronic and congenital heart disease and use of non-steroidal anti-
inflammatory drugs. Data were analyzed using SPSS v. 19 software; descriptive statistics, 
independent t-tests, and the Pearson test were also performed. Results: We studied 48 pregnant 
women and their neonates. Approximately 40% of women had chorioamnionitis; approximately 
60% of women did not have chorioamnionitis. Moreover, approximately 69% of the neonates 
had a 5-minute Apgar score ≥7. A significant correlation was observed between women who 
had histopathology confirmed chorioamnionitis and neonate hospitalization in the neonatal 
intensive care unit (P<0.001). The sensitivity, specificity, and positive and negative predictive 
values of PCT inflammatory indices were 100%, 79%, 57.5%, and 100%, respectively, for the 
histopathologic diagnosis of chorioamnionitis. Conclusion: In pregnant women, we found a 
significant correlation between PCT index at delivery and histopathologic chorioamnionitis.
INTRODUCTION
Premature rupture of membrane (PROM) is the rupture of 
fetal membranes at least 1 hour before the onset of labor 
pain; it occurs in approximately 10% of pregnancies. A third 
of PROM cases occur before week 37 of pregnancy and are 
referred to as preterm PROM (PPROM) (1). In a study of 
PROM in Vali-e-Asr Hospital in Tehran, Iran, Nili and An-
sari reported an incidence rate of 7% (2). PPROM is divid-
ed into three groups: 1) non-viable fetus (before week 23 
of pregnancy); 2) rupture of membranes from fetal viabili-
ty to week 31 of pregnancy; and 3) from week 32 to week 
36 of pregnancy (3). The cause of PROM has not yet been 
determined (4); however, important risk factors for PROM 
include gestational age, low maternal body mass index 
(˂19.8 kg/m2), low social and economic status of the mother, 
history of cervical conization, smoking, genital infections, 
excessive elongation of the membranes (due to polyhydram-
nios or multiple pregnancies), history of PPROM, nutrition-
al factors (deficiency of copper and ascorbic acid), cervical 
incompetence, cervical cerclage, and placental detachment 
(second and third trimester bleeding) (5). The complications 
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of PROM before the onset of labor pain include maternal 
infections (e.g., endometriosis or sepsis), chorioamnionitis 
(9% in term PROM and 13-60% in preterm PROM), placen-
tal detachment, fetal infections, neonatal death, low Apgar 
score, umbilical cord compression and prolapse, pulmonary 
hypoplasia, and low birth weight (6, 7). Infections causing 
PROM include chlamydia trachomatis, trichomonas vagina-
lis, Neisseria gonorrhea, and Group-B streptococcus (5). The 
mean duration of hospitalization of PROM and PPROM ne-
onates increases by 20% and 25%, respectively, compared to 
other neonates, and their imposed costs on the health system 
increase by 31% and 60%, respectively (8). Chorioamnion-
itis is the infectious inflammation of the uterine cavity, fetal 
membranes (amnion and chorion), and placenta, with certain 
maternal and fetal complications (9, 10). In cases of chorio-
amnionitis, fever ≥38˚C (≥100.4˚F) and ruptured membranes 
are the only reliable indicators of the disease; nevertheless, it 
is necessary to monitor uterine tenderness, permanent mater-
nal or fetal tachycardia, and smelly vaginal discharge (11). 
However, a definitive diagnosis is reached only after micro-
scopic observations (12). Procalcitonin (PCT) is a 116-ami-
no acid-containing polypeptide precursor of the hormone 
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calcitonin that is processed to calcitonin and one 32-ami-
no acid polypeptide via endopeptidase enzymes (13). The 
serum level of PCT increases within 2-6 hours after sepsis 
but decreases in the case of infection control (14, 15). Since 
chorioamnionitis is a bacterial infection that causes sepsis 
and since serum PCT increases in bacterial infections, PCT 
increase appears to be effective in the early diagnosis of 
chorioamnionitis, early termination of pregnancy, and fetal 
therapy. One study found that the sensitivity and specifici-
ty of the maternal serum level of PCT were 50% and 56%, 
respectively, for the histopathologic diagnosis of chorioam-
nionitis (16).
Because of the limited number of studies and the signifi-
cant effects that early diagnosis of chorioamnionitis can have 
in reducing maternal and neonatal complications, we sought 
in this study, which was conducted in 2016, to determine the 
predictive value of PCT in the early diagnosis of chorioam-
nionitis in pregnant women with PPROM. Our purpose was 
to increase the knowledge in this field and reduce maternal 
and fetal complications of chorioamnionitis by proving the 
applicability of PCT in treatment interventions and patient 
management.
METHODS
Our study included pregnant women with PPROM who 
underwent conventional therapy in the Kosar Ward of 
Motahari Hospital in Urmia, Iran. This prospective cohort 
study was done during 18 months. In this prospective cohort 
study, owing to limited financial resources and in accor-
dance with previous studies of patients treated in the same 
ward, 48 patients with PPROM were selected to comprise 
the sample (2, 4, 8).
Pertinent medical information was obtained from the 
completion of a questionnaire, from lab test results, and 
from histologic examinations. Demographic information 
was obtained from self-report dossiers, and laboratory 
variables were obtained from laboratory reports. The in-
cluded patients were pregnant women who were hospital-
ized in the midwifery ward of Shahid Motahari Hospital 
because of rupture of membranes at the gestational age of 
28-33 weeks.
Upon hospital admission, patients underwent blood sam-
pling for screening PCT. Afterwards, they underwent treat-
ment in the hospital. Immediately after delivery (vaginal or 
cesarean section), a blood sample was retaken to screen for 
PCT. Then, the placentas of all patients were transferred to 
the pathology laboratory for histologic examination for cho-
rioamnionitis.
In the pathology laboratory, the stages of sample prepara-
tion were as follows:
1. After isolating the samples fixed in formalin, tissue-pro-
cessing steps included: 1) additional fixation in formalin 
solution; 2) dehydration in 75-, 85-, and 96-degree al-
cohol and absolute alcohol; 3) clearing in xylene solu-
tion; and 4) saturation in molten paraffin via a tissue 
processor.
2. Sample molding by paraffin and paraffin blocks.
3. Cutting the blocks to a thickness of 4 microns by a mi-
cro-thermometer and transferring the tissues.
4. Paraffinizing the isolated tissues in a dry heat or oven.
5. Hematoxylin and eosin staining as follows:
5.1.  Hydrating tissues in 96-, 85-, and 75-degree 
alcohol
 5.2. Washing with water
 5.3. Staining with hematoxylin
 5.4. Washing with water
 5.5. De-staining (decoloring) in alcoholic acid
 5.6. Washing with water
 5.7. Alkalizing tissues by bicarbonates
 5.8. Washing with water
 5.9. Staining with eosin
 5.10. Washing with water
 5.11. Dehydrating with reverse alcohol
 5.12. Clearing in xylene solution
 5.13. Laminating with Entellan Merck
Notably, chorioamnionitis is pathologically characterized 
as a leukocyte infiltration with neutrophilic priority and in-
flammatory infiltration on the fetal membranes (16).
Finally, the patients were divided into three groups:
1. Pregnant women with clinical symptoms of chorioamni-
onitis
2. Pregnant women with histopathologic chorioamnionitis
3. Pregnant women with none of the above symptoms 
(clinical or histologic chorioamnionitis)
Patients underwent clinical examination for fever and fe-
tal tachycardia using non-skid tape  24 hours before the on-
set of delivery. The antibiotic treatment was used to prevent 
neonatal sepsis in the patients under observation.
Next, the inflammatory indices were compared in each 
group. Serum levels of PCT higher than 0.06 ng/ml were 
considered an increased amount. This amount was selected 
because of the use of different cutoff points in the reviewed 
articles, the population proximity of the neighboring country, 
Turkey, to Iran, and the novelty of our study (8, 17). A cobas 
e411 analyzer and a Roche diagnostic kit (Lot 187-424-02) 
were used to measure the level of PCT.
A two-way blindness process was used between the 
histology group and the laboratory responsible for mon-
itoring the maternal serum level of PCT. To evaluate the 
value of PCT in diagnosing chorioamnionitis, PCT levels 
were compared with clinical symptoms, histologic results, 
specificity index, sensitivity index, positive and negative 
predictive values, and Youden’s index. Inclusion criteria 
included proof of amniotic fluid leak via speculum exam-
ination, positive nitrazine and ferning test, gestational age 
of 28-33 weeks that was approved to be less than 20 weeks 
us ultrasonography, lack of fever, uterine contractions, ab-
normal vaginal discharge on the first day of hospitalization, 
absence of vaginal bleeding, and lack of fetal tachycardia. 
Exclusion criteria included congenital heart disease, heart 
valve surgery, chronic vascular disease (nephritic syndrome 
or lupus), use of corticosteroids, or use of nonsteroidal an-
ti-inflammatory drugs.
This study was approved by the Ethics Committee of 
Urmia University of Medical Sciences. All patients were 
informed about the research process. Researchers did not 
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intervene in the conventional process, management, or treat-
ment of patients.
Data were analyzed using SPSS v. 19 software; descrip-
tive statistics, independent t-tests, and the Pearson test were 
also performed. P values less than 0.05 were considered sta-
tistically significant.
RESULTS
In this study of 48 women with PPROM, we sought to de-
termine the predictive value of maternal serum level of PCT 
in diagnosing chorioamnionitis. Patient demographic char-
acteristics are shown in Table 1.
Twenty-three patients (47.9%) tested positive for 
PPROM based on clear amniotic fluid leak, and 25 patients 
(52.1%) tested positive for PPROM based on the nitrazine 
and ferning test. The gestational age of nine patients (18.8%) 
had valid last menstrual period (LMP), 34 (50%) was before 
week 12 based on ultrasonography, and 15 (39.9%) was be-
fore week 20 based on ultrasonography. In 48 patients, the 
minimum gestational age at PROM was 28 weeks and 5 days; 
the maximum gestational age at PROM was 33 weeks. The 
mean time of PPROM was 31 weeks and 6 days (± 1 week 
and 2 days). Moreover, the minimum gestational age at de-
livery was 29 weeks and 5 days; the maximum gestational 
age at delivery was 34 weeks. The mean delivery time was 
33 weeks and 2 days (± 1 week). In terms of 5-minute Apgar 
score, three neonates (6.2%) scored 4, seven (14.6%) scored 
5, five (10.4%) scored 6, and 33 (68.8%) scored 7. The min-
imum birth weight was 1200 g; the maximum birth weight 
was 2200 g. The mean birth weight was 1927.1 g ± 232.31 g. 
In terms of amniotic fluid index in the last ultrasonography 
before delivery, the minimum and maximum indices were 
0 mm and 38 mm, respectively. The mean fluid index was 
19.42 mm ± 9.91 mm.
As shown in Table 2, in terms of PCT inflammatory in-
dex upon hospitalization, the minimum and maximum val-
ues were 0.02 and 0.1, respectively, and the mean index was 
0.041 ± 0.017. The minimum and maximum PCT indices 
upon delivery were 0.95 and 0.03, respectively, and the 
mean index was 0.104 ± 0.175. No statistically significant 
correlation was observed between PCT level upon hospital-
ization and delivery time (R2=0.04 and P˂0.176).
As shown in Table 3, all women with a PCT index ≥0.06 
upon hospitalization had chorioamnionitis. Moreover, of 
the women with a negative PCT index upon hospitalization, 
17 (37%) had chorioamnionitis and 29 (63%) did not have 
chorioamnionitis. According to the chi-squared test and the 
Pearson correlation test, no significant correlation was ob-
served between PCT index upon hospitalization and infec-
tion with chorioamnionitis (P=0.077).
As shown in Table 4, of the women with a PCT index 
≥0.06 upon delivery, 16 (66.7%) had chorioamnionitis and 
eight (33.3%) did not have chorioamnionitis. Moreover, of 
the women with a negative PCT index upon delivery, three 
(12.5%) had chorioamnionitis and 21 (87.5%) did not have 
chorioamnionitis. According to the chi-squared test and the 
Pearson correlation test, a significant correlation was ob-
served between PCT index upon delivery and infection with 
chorioamnionitis (P=0.0). The odds ratio (OR) of chorioam-
nionitis in women with increased PCT index upon delivery 
was infinite (not defined) (OR=∞).
DISCUSSION
Histologic chorioamnionitis (i.e. infection of fetal mem-
branes and amniotic fluid) is commonly observed in preg-
nant women with PPROM and may cause neonatal sepsis, 
preterm birth, pulmonary diseases, and neonatal brain injury. 
Therefore, early diagnosis of chorioamnionitis is very im-
portant (18, 19). PCT is a peptide precursor of the calcitonin 
hormone, which is typically produced by monocytes and 
hepatocytes (20). The serum level of PCT rapidly increases 
in response to bacterial endotoxin within 3-4 hours, peaks 
within 18-24 hours, and remains at its elevated serum level 
within 24-48 hours (20).
We found a significant correlation between maternal in-
fection with histologic chorioamnionitis and the inflamma-
tory index of PCT upon delivery. However, we did not find 
a significant correlation between maternal infections and 
chorioamnionitis.
As reported in a clinical study, maternal serum level of 
PCT upon hospitalization of women with PPROM (up to 
4 hours after rupture of membrane) was not a reliable index 
to diagnose histologic chorioamnionitis, fetal infection, time 
Table 1. Demographic characteristics of the pregnant 
women
Variable Frequency Percentage
G≤2 33 68.7
G≥3 15 31.3
PPROM 6 12.5
Abortion 6 12.5
G: Gestational age, PPROM: Preterm Premature Rupture of 
Membrane
Table 2. Minimum and maximum inflammatory indices upon hospitalization and delivery
Variable No. Minimum Maximum Mean SD
PCT upon hospitalization 48 0.02 0.10 0.041 0.017
PCT upon delivery 48 0.03 0.95 0.104 0.175
Last measured index of amniotic fluid 48 0 38 19.42 9.91
Days of hospitalization until delivery 48 2 30 10.29 5.52
PCT: Procalcitonin, SD: Standard deviation
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interval between PROM and delivery, or intrauterine infec-
tion. However, the maternal serum level of PCT in women 
with PPROM was higher than the maternal serum level of 
PCT in women without PPROM (21). A prospective study 
found that the increased maternal serum level of C-reactive 
protein (CRP) and PCT upon delivery significantly correlat-
ed with histologic chorioamnionitis regardless of membrane 
status (22). Oludaq et al. showed that the maternal serum 
level of PCT in women with PPROM who also had histo-
logic chorioamnionitis was significantly higher than the 
maternal serum level of PCT in women with PPROM who 
did not have chorioamnionitis. Moreover, the sensitivity and 
specificity of PCT were 92.3% and 68.4%, respectively, at 
0.054 ng/ml serum level for the diagnosis of chorioamnio-
nitis (17).
In our study, the causes of neonatal death included pul-
monary hemorrhage, acute respiratory distress syndrome 
(ARDS), and cerebral hemorrhage. An observational study 
found that cognitive disorders, neuro-developmental disor-
ders, and mortality were significantly higher in neonates with 
a gestational age of ≤27 weeks who were born to mothers 
with chorioamnionitis than in other neonates (23). As report-
ed in a retrospective study, prenatal corticosteroid adminis-
tration was associated with a significant decrease in neonatal 
mortality, ARDS, neonatal seizure, and cerebral hemorrhage 
in neonates born to mothers with histologic chorioamnion-
itis (24). Another retrospective study showed that prenatal 
cortisone administration reduced the mortality rate before 
the age of 3 years in children of mothers who had histologic 
chorioamnionitis, as compared to children of non-infected 
mothers; however, prenatal cortisone administration did not 
have any effect on the neuro-developmental rate of children 
born to mothers in both infected and non-infected groups. 
Therefore, corticosteroids are recommended to mothers with 
chorioamnionitis (25).
A retrospective study of neonates with a low birth weight 
of ≤1500 g born to mothers with chorioamnionitis found that 
histologic chorioamnionitis was associated with an increased 
risk of chronic pulmonary disease and neonatal sepsis; how-
ever, histologic chorioamnionitis did not correlate with cere-
broventricular hemorrhage, periventricular leukomalacia, 
cerebral palsy, vision impairment, or neonatal death before 
discharge (26, 27).
Recently, a novel antibiotic regimen based on ceftriax-
one, clarithromycin, and metronidazole has been used for 
the treatment of chorioamnionitis; this regimen has result-
ed in less maternal infection with histologic chorioamnio-
nitis as compared to the ampicillin regimen with or without 
cephalosporin. Accordingly, the rates of cerebral palsy and 
ventricular hemorrhage were significantly lower in neonates 
treated with the new regimen than in neonates treated with 
the ampicillin (28, 29).
Limitations of our study included the high costs and lim-
ited financial resources to measure the serial serum level of 
PCT and to compare the intended patients with healthy non-
PPROM pregnant women.
CONCLUSION
We found a significant correlation between PCT index at 
delivery time and histopathologic chorioamnionitis. We also 
found a significant correlation between the inflammatory in-
dices of CRP during the delivery time and histopathologic 
chorioamnionitis.
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Table 3. Mean±standard deviation and frequency of 
inflammatory indices with respect to women with 
chorioamnionitis
Variable Chorioamnionitis Total
Yes No
PCT>0.06 upon hospitalization
Positive
Frequency 2 0 2
Percent 100 0 100
Negative
Frequency 17 29 46
Percent 37 63 100
Total
Frequency 19 29 48
Percent 39.6 60.4 100
PCT: Procalcitonin
Table 4. Mean and standard deviation (SD) of inflammatory indices with respect to women with chorioamnionitis
Variable Chorioamnionitis No. Mean SD
PCT>0.06 upon hospitalization Positive 19 0.045 0.021
Negative 29 0.038 0.012
PCT>0.06 upon delivery Positive 19 0.18 0.265
Negative 29 0.056 0.018
PCT: Procalcitonin, SD: Standard deviation
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